Impax Labs (IPXL) hires a new CEO

 

Impax Labs appoints Paul M. Bisaro as President and CEO effective immediately :

Bisaro previously served as Executive Chairman of Allergan (AGN), President and CEO of Actavis (formerly Watson Pharmaceuticals, Inc.) and Chairman of the Board.

• Bisaro will succeed J. Kevin Buchi, who has served as Interim President and CEO since December of 2016

** chart before  **